Government's Healthcare Pricing Premium Policy Can Favour Foreign Multinationals

BMI View: Multinational drug companies and medical device makers can benefit from the Brazilian government's promotion of the local industry by collaborating with local companies to access the regional market, thereby enjoying the government's incentive scheme and enhancing their market share in this promising emerging pharmaceutical market.

To read the full article, please choose one of the following options: